Clinical Trial Update: Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

An update on a completed Phase 1/2 trial evaluating autologous mesenchymal stem cell transplantation for multiple sclerosis. The report summarizes observed effe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED